Civic AI
Procurement intelligence
Federal contract award
NICHD: R&D: OVAPRENE VAGINAL DEVICE CLINICAL TRIAL PHASE 1: NON-SEVERABLE
BOSTON MEDICAL CENTER CORPORATION · Department of Health and Human Services
- Value
- $113,357
- Start
- Sep 28, 2023
- End
- Feb 28, 2026
- Action date
- Apr 21, 2026
- PIID
- 75N94023F00001
- Status
- completed
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- BOSTON, MA
- Award type
- DELIVERY ORDER
Description
NICHD: R&D: OVAPRENE VAGINAL DEVICE CLINICAL TRIAL PHASE 1: NON-SEVERABLE
Need modifications, related awards, and vendor peers? Open the full award workspace.